Annalisa Luraschi
Annalisa Luraschi publishes mostly in Hematology, Oncology and Genetics, on topics such as Multiple Myeloma Research and Treatments, Cancer Treatment and Pharmacology and Lymphoma Diagnosis and Treatment.
- World rank
- #7,127,971 of 7,710,434 ranked researchers
- Rank in Italy
- #228,089 of 242,206
- Works
- 25
- Citations
- 175
- Citations per work
- 7.0
What does Annalisa Luraschi research?
Annalisa Luraschi's work is mostly in Medicine (57%), Immunology and Microbiology (7%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1457.1%
- Medicine1457.1%
- Everything else830.4%
- Life Sciences312.5%
- 1Hematology27% of their works
- 2Oncology11% of their works
- 3Genetics11% of their works
- 4Pathology and Forensic Medicine9% of their works
- 5Immunology7% of their works
- 6Molecular Biology5% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Cancer Treatment and Pharmacology
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Immunodeficiency and Autoimmune Disorders
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Which keywords describe Annalisa Luraschi's research?
The keywords of their largest research topics: Rituximab, Prognostic Factors, Diagnosis Criteria, Hematopoietic Stem Cells, International Myeloma Working Group, Chemotherapy-Induced Peripheral Neuropathy, Classification and Lymphoma.
- JAK2 Mutation
- Graft-versus-Host Disease
- Bone Marrow Niche
- AML
- Chronic Lymphocytic Leukemia
- Lymphoma
- Chemotherapy-Induced Peripheral Neuropathy
- Hematopoietic Stem Cells
- Prognostic Factors
- Rituximab
- Diagnosis Criteria
- International Myeloma Working Group
- Classification
- Taxanes
- Genomic Aberrations
- Acute Myeloid Leukemia
- Genetic Mutations
- Primary Immunodeficiency
- Myelofibrosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Rituximab92 topics
- Prognostic Factors72 topics
- Diagnosis Criteria61 topic
- Hematopoietic Stem Cells62 topics
- International Myeloma Working Group61 topic
- Chemotherapy-Induced Peripheral Neuropathy51 topic
- Classification51 topic
- Lymphoma51 topic
- Taxanes51 topic
- Chronic Lymphocytic Leukemia41 topic
- Genomic Aberrations41 topic
- AML31 topic
- Acute Myeloid Leukemia31 topic
- Bone Marrow Niche31 topic
- Genetic Mutations31 topic
- Graft-versus-Host Disease31 topic
- Primary Immunodeficiency31 topic
- JAK2 Mutation21 topic
- Myelofibrosis21 topic
Where does Annalisa Luraschi work?
Annalisa Luraschi's main affiliation in the publication record is Istituti di Ricovero e Cura a Carattere Scientifico, Italy.
How many publications and citations does Annalisa Luraschi have?
OpenAlex counts 25 works and 175 citations for Annalisa Luraschi, an h-index of 7, ranking #7,127,971 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Annalisa Luraschi. Posts are plain text and can be reported.